Who May Be Considered for Sleeve Gastrectomy?

What is sleeve gastrectomy?

Sleeve gastrectomy is a metabolic and bariatric procedure in which a large portion of the stomach is removed, leaving a narrower, sleeve-shaped stomach. It can reduce stomach capacity and may also affect appetite and metabolic signalling. It is not automatically suitable for everyone with obesity. This guide is general information and guidance only; it is not a diagnosis, a personal recommendation or a substitute for assessment by a qualified clinician.

Who may be considered?

Assessment usually looks at several factors together: body mass index (BMI), weight history, obesity-related health conditions, previous non-surgical treatment, eating patterns, psychological readiness, anaesthetic and surgical risk, and the ability to engage in long-term follow-up. Current international professional guidance may support consideration of metabolic and bariatric surgery for adults with a BMI of 35 kg/m² or above. People with a BMI of 30–34.9 kg/m² may also be considered in selected circumstances, especially where metabolic disease is present or substantial, durable improvement has not been achieved with non-surgical treatment. These thresholds are only a general framework and do not determine individual eligibility on their own.

Why do obesity-related conditions matter?

Type 2 diabetes, obstructive sleep apnoea, high blood pressure, fatty liver disease, joint problems and other metabolic conditions can influence the balance of potential benefit and risk. Having one of these conditions does not automatically mean surgery is appropriate, and not having them does not automatically rule surgery out. A specialist team should review the whole clinical picture before making a recommendation.

Must non-surgical weight-loss methods have been tried first?

Nutrition support, physical activity, behavioural strategies and, where appropriate, anti-obesity medication are often part of the treatment history. Modern obesity care should not be reduced to whether a person has “tried hard enough” to diet. Obesity is a chronic, multifactorial disease. Previous treatments, weight cycling, health risks and personal goals should all be reviewed when surgery is discussed.

Is sleeve gastrectomy equally suitable for everyone with obesity?

No. For example, people with significant or difficult-to-control gastro-oesophageal reflux may need to discuss whether another bariatric procedure could be more appropriate. Previous abdominal surgery, gastrointestinal disease, nutritional deficiencies, active substance use, pregnancy or near-term pregnancy plans, uncontrolled severe mental health conditions, eating-related concerns and certain high surgical risks can all change the decision. These factors should not be treated as universal absolute exclusions; they require individual specialist assessment.

What may be assessed before surgery?

Depending on the person and the centre, evaluation may include blood tests, nutritional assessment, internal medicine or endocrinology review, anaesthetic assessment, psychological or behavioural assessment, screening for sleep apnoea, cardiology review and, when indicated, upper gastrointestinal endoscopy. The aim is not simply to “approve” surgery, but to identify risks, select the most appropriate procedure and plan long-term care.

Why does long-term follow-up matter?

Sleeve gastrectomy does not guarantee a specific or permanent amount of weight loss. Post-operative nutrition stages, adequate protein and fluid intake, vitamin and mineral supplementation, physical activity, routine clinical review and long-term weight monitoring are important. Suitability therefore includes whether a person can realistically engage with follow-up and lifestyle changes over time.

How can Clinicly support people considering treatment in Türkiye?

For international patients exploring sleeve gastrectomy in Türkiye, Clinicly can help coordinate the transfer of medical information, contact with appropriate hospitals and specialists, appointments and practical travel arrangements. Clinicly does not decide whether someone is medically suitable for surgery. The final recommendation, procedure choice and risk discussion should be made by the bariatric surgical team and other relevant clinicians after individual assessment.

Frequently asked questions

Can sleeve gastrectomy be considered if BMI is below 35?

It may be considered in selected people. Some current professional guidance includes consideration of metabolic and bariatric surgery for BMI 30–34.9 kg/m² when metabolic disease is present or when non-surgical treatment has not produced substantial and durable improvement. This is not a personal treatment recommendation; a specialist assessment is still required.

Does type 2 diabetes automatically make someone a candidate?

No. Type 2 diabetes can be an important factor, but duration of diabetes, current medication, BMI, reflux, other health conditions, surgical risk and personal goals also matter.

What if someone has reflux?

Sleeve gastrectomy can worsen reflux in some people. When reflux is significant, the surgeon may discuss alternative procedures and may recommend additional investigations such as endoscopy before deciding.

Does sleeve gastrectomy guarantee weight loss?

No. Weight loss and long-term maintenance vary between individuals. Starting weight, surgical factors, eating behaviour, physical activity, metabolic factors and engagement with follow-up can all influence outcomes.

Could another bariatric procedure be recommended instead?

Yes. Gastric bypass and other metabolic-bariatric procedures may be more appropriate for some people. The choice depends on reflux, diabetes, BMI, eating patterns, previous surgery, individual goals and the specialist team’s assessment.

Conclusion

Sleeve gastrectomy may be a reasonable option for some adults living with obesity, but there is no single BMI value or diagnosis that can determine suitability on its own. BMI, metabolic disease, previous treatment, reflux, nutritional status, psychological readiness, surgical risk and the ability to maintain long-term follow-up should all be considered together. Clinicly can help international patients organise consultations and treatment planning in Türkiye, while the final medical recommendation should always be made by qualified specialists after an individual assessment.